Initial public offering of Genmab A/S (DK) — DKK 1.6 billion

Carnegie acted as co-lead manager in the initial public offering of Genmab A/S on the Copenhagen Stock Exchange. Genmab A/S is a Danish biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases.October, 2000.